Pulse Biosciences to Participate in Upcoming Investor Conferences
March 05 2021 - 8:00AM
Business Wire
Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric
medicine company progressing Nano-Pulse Stimulation™ (NPS™)
technology, today announced plans to participate in two upcoming
virtual investor conferences.
Management is scheduled to participate in the H.C. Wainwright
Global Life Sciences Conference hosting one-on-one meetings
Wednesday, March 10, 2021. A presentation webcast will be available
in advance of the event on Tuesday, March 9, 2021 at 7:00am ET.
Management is scheduled to participate in an aesthetic
dermatology panel discussion during the Maxim Emerging Growth
Virtual Conference on Wednesday, March 17, 2021. A live and
recorded webcast of the panel discussion will be available at
2:00pm ET on the same day. A presentation by management will also
be available at the start of the event at 9:00am ET on Wednesday,
March 17, 2021.
Interested parties may access the on-demand webcasts from both
conferences on the “Investors” section of the Company’s website at
www.pulsebiosciences.com.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company
committed to health innovation that has the potential to improve
the quality of life for patients. The CellFX® System is the first
commercial product to harness the distinctive advantages of the
Company’s proprietary Nano-Pulse Stimulation™ (NPS™) technology,
such as the ability to non-thermally clear cells while sparing
non-cellular tissue, to treat a variety of applications for which
an optimal solution remains unfulfilled. Nano-Pulse Stimulation
technology delivers nano-second pulses of electrical energy. The
initial commercial use of the CellFX System is to address a range
of dermatologic conditions that share high demand among patients
and practitioners for improved dermatologic outcomes. Designed as a
multi-application platform, the CellFX System offers customer value
with a utilization-based revenue model. To learn more, please visit
pulsebiosciences.com.
To stay informed about the CellFX System, please visit
CellFX.com and sign up for updates.
Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the
stylized logos are among the trademarks and/or registered
trademarks of Pulse Biosciences, Inc. in the United States and
other countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210305005107/en/
Investors: Pulse Biosciences Sandra Gardiner, EVP and CFO
510.241.1077 IR@pulsebiosciences.com or Gilmartin Group Philip Trip
Taylor 415.937.5406 philip@gilmartinir.com
Media: Tosk Communications Nadine D. Tosk 504.453.8344
nadinepr@gmail.com or press@pulsebiosciences.com
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Apr 2023 to Apr 2024